Haemonetics Corporation (HAE)
Upgrades & Downgrades
Latest HAE news
Haemonetics: Upside Case Hinges On Blood Plasma Collection Market
11 June 2022
The debate on Haemonetics largely rests on growth in the blood plasma market. More than 35% of revenues are exposed to this segment, and growth of the market has been volatile in recent years.
Haemonetics (HAE) Up 28.2% Since Last Earnings Report: Can It Continue?
9 June 2022
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock?
Here's Why Investors Should Retain Haemonetics (HAE) For Now
23 May 2022
Investors are optimistic about Haemonetics's (HAE) better-than-expected results and robust segmental performance.
Haemonetics (HAE) Q4 Earnings Top Estimates, Gross Margin Up
11 May 2022
Robust performance by Plasma and Hospital businesses drove Haemonetics' (HAE) revenues in the fiscal fourth quarter.
Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2022 Results - Earnings Call Transcript
10 May 2022
Haemonetics Corporation (NYSE:HAE ) Q4 2022 Results Conference Call May 10, 2022 8:00 AM ET Company Participants Olga Guyette - Director, IR and Treasury Chris Simon - CEO James D'Arecca - CFO Confere...
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
10 May 2022
Haemonetics (HAE) delivered earnings and revenue surprises of 8.33% and 2.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Medical Product Stocks Set to Beat on Earnings This Season
9 May 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.
Here's Why You Should Hold on to Haemonetics (HAE) For Now
14 April 2022
Investors are optimistic about Haemonetics (HAE) given the strength in its Hemostasis Management franchise and increased product uptake.
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022
6 April 2022
BOSTON, April 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2022 financial results at 6:00 am EDT on Tuesday, May...